Author Index

Search or browse for an author across our entire electronic archive

Search results for: M
Results 1 - 10 of 2577 shown below

  • Máximo, V

    V Máximo, T Botelho, J Capela, P Soares, J Lima, A Taveira, T Amaro, A P Barbosa, A Preto, H R Harach, D Williams and M Sobrinho-Simões

    Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid

    advance online publication, 2005-04-19 00:00:00.000;

    doi:10.1038/sj.bjc.6602547

  • Mæhle, B O

    L J Vatten, B O Mæhle, T I Lund Nilsen, S Tretli, C-c Hsieh, D Trichopoulos and S O Stuver

    Birth weight as a predictor of breast cancer: a case-control study in Norway

    doi:10.1038/sj.bjc.6600011

  • Mæhlen, J

    P C Gøtzsche, K J Jørgensen, J Mæhlen and P-H Zahl

    Estimation of lead time and overdiagnosis in breast cancer screening

    doi:10.1038/sj.bjc.6604762

  • N Wessel, K Liestøl, J Mæhlen and S H Brorson

    The apolipoprotein E alt epsilon 4 allele is no risk factor for prostate cancer in the Norwegian population

    doi:10.1054/bjoc.2001.2098

  • Mælandsmo, G M

    K B Pedersen, J M Nesland, Ø Fodstad and G M Mælandsmo

    Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies

    doi:10.1038/sj.bjc.6600624

  • K Andersen, B Smith-Sørensen, K B Pedersen, E Hovig, O Myklebost, Ø Fodstad and G M Mælandsmo

    Interferon-italic gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest

    doi:10.1038/sj.bjc.6600998

  • A Fosså, R Siebert, H-C Aasheim, G M Mælandsmo, A Berner, S D Fosså, E Paus, E B Smeland and G Gaudernack

    Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

    doi:10.1054/bjoc.2000.1365

  • Ma ogondry, R

    J Kupryjan acuteczyk, T Szyman acuteska, R Ma ogondry, A Timorek, J Stelmachów, G Karpin acuteska, A Rembiszewska, I Ziól strokekowska, E Kraszewska, J De ogonbniak, J Emerich, M Ul strokean acuteska, A Pl strokeuzdotan acuteska, M Je ogondryka, M Goluda, A Chudecka-Gl strokeaz, I Rzepka-Górska, M Klimek, K Urban acuteski, J Bre ogonborowicz, J Zielin acuteski and J Markowska

    Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

    doi:10.1038/sj.bjc.6600789

  • J Kupryjan acuteczyk, R Ma ogondry, J Plisiecka-Hal strokeasa, J Bar, E Kraszewska, I Ziól strokekowska, A Timorek, J Stelmachów, J Emerich, M Je ogondryka, A Pl strokeuzdotan acuteska, I Rzepka-Górska, K Urban acuteski, J Zielin acuteski and J Markowska

    TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

    advance online publication, 2004-11-16 00:00:00.000;

    doi:10.1038/sj.bjc.6602238

  • M'Rabet, L

    B van't Land, H P Meijer, J Frerichs, M Koetsier, D Jager, R L Smeets, L M'Rabet and M Hoijer

    Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling

    doi:10.1038/sj.bjc.6600342

  • Mårlind, J

    J K J Ahlskog, C Schliemann, J Mårlind, U Qureshi, A Ammar, R B Pedley and D Neri

    Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours

    advance online publication, 2009-07-21 00:00:00.000;

    doi:10.1038/sj.bjc.6605200

  • Måsbäck, A

    J Westerdahl, C Ingvar, A Måsbäck, N Jonsson and H Olsson

    Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity

    doi:10.1054/bjoc.1999.1181

  • Määttänen, L

    L Määttänen, M Hakama, T L J Tammela, M Ruutu, M Ala-Opas, H Juusela, P Martikainen, U-H Stenman and A Auvinen

    Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

    doi:10.1038/sj.bjc.6603522

  • T J Murtola, T L J Tammela, L Määttänen, M Ala-opas, U H Stenman and A Auvinen

    Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

    advance online publication, 2009-08-04 00:00:00.000;

    doi:10.1038/sj.bjc.6605188

  • L Määttänen, A Auvinen, U-H Stenman, S Rannikko, T Tammela, J Aro, H Juusela and M Hakama

    European randomized study of prostate cancer screening: first-year results of the Finnish trial

    doi:10.1038/sj.bjc.6690194

  • Mäcke, H

    L Kölby, P Bernhardt, V Johanson, A Schmitt, H Ahlman, E Forssell-Aronsson, H Mäcke and O Nilsson

    Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour

    advance online publication, 2005-10-25 00:00:00.000;

    doi:10.1038/sj.bjc.6602845